Delivery Order SPE2DB22D6029-SPE2DB25FLTZT

Award Date 2/5/25
Potential Completion Date 2/27/25
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of XOLAIR 150 mg/mL autoinjectors, with a ceiling value of $8,475.96 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp., a major pharmaceutical distribution company. The $38,522.50 firm-fixed-price contract is for the supply of XOLAIR 150 MG/ML autoinjectors, with a completion date of May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $38,846.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $4,415.81 and a completion date of February 4, 2025. It is a Firm Fixed Price Delivery Order contract for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET, which is used for various medical treatments. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $4,933.67 firm fixed-price delivery order is for the specialty pharmaceutical drug Xeljanz XR 11 mg tablets. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566771243 XELJANZ XR 11 MG TABLET UU 30S. The firm-fixed-price delivery order has a ceiling value of $8,723.07 and a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating an open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp is a $28,933.93 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA). The contract is to provide XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp is a large pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal agencies, particularly the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,018.34 delivery order contract is for the supply of Xeljanz XR 11 mg tablets to support military and veterans' healthcare programs. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., and has established itself as a key vendor for the DLA and other federal agencies,...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $3,094.80 and an ultimate completion date of February 3, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, specifically the drug XELJANZ XR 11MG TB 30S. The contract has a ceiling value of $20,862.04 and an ultimate completion date of October 1, 2024. It is a delivery order contract with a firm fixed price pricing type. There is no set-aside designation indicated. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTZT
    Delivery Order

This federal contract award, valued at $8,342.40, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XOLAIR 150 MG/1.2 ML POWDER VLS, a pharmaceutical product, with a completion date of February 27, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/7/25, 9:56 AM